DBV Technologies elects George Horner as non-executive Chairman of the Board of Directors to advance the clinical development of VIASKIN[R] Peanut, the world's first epicutaneous skin patch for desensitization of peanut allergy.

Extract


DBV Technologies elects George Horner as non-executive Chairman of the Board of Directors to advance the clinical development of VIASKIN[R] Peanut, the world's first epicutaneous skin patch for desensitization of peanut allergy.

"George Horner's 40 years of pharmaceutical industry experience will be a considerable asset to the further development of our VIASKIN[R] technology, which of...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company